semaglutide cheaper alternative Novo Nordisk introduces low-cost alternatives to diabetes drugs in Brazil Cheaper obesity medications could come

This membership gives you access to the full WeightWatchers program: clinician support, app tracking, WW Points, and coaching tools

Combining GLP-1 agonists is not supported by any clinical evidence and is universally discouraged by healthcare providers

And, with skyrocketing costs associated with these medications, 96% of employers worry about the long-term cost implications of covering GLP-1s

The term "GLP-1" stands for glucagon-like peptide-1, a hormone naturally produced in the intestines that plays several roles in metabolism and appetite regulation

Patients on Medicare or Medicaid are typically not eligible

Not for use during pregnancy or nursing without guidance from your provider